248.524.01001 Boehringer Ingelheim Investigational Site

Kansas City, Kansas

0 studies enrolling now · 1 studies all time

What they study most

Early Parkinson Disease (Early PD)

Studies at this site

• Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD Patients — Completed